Clifutinib
HEC73543-AML-301
Phase 3 small_molecule active
Quick answer
Clifutinib for Leukemia, Acute Myeloid (AML) is a Phase 3 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Leukemia, Acute Myeloid (AML)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active